Author Archive: AZBio

Payroll R&D Credit Five Years Later: Forging a New Path

Posted on by

By John Guy, Manager, Emerging Companies Policy at Biotechnology Innovation Organization

December 18, 2020:  Five years ago today, the Protecting Americans from Tax Hikes (PATH) Act was signed into law. This important piece of legislation included several provisions helpful to start ups like small biotechs, including permanently extending both the R&D Credit and the Small Business Stock Gains Exclusion (Tax Code Section 1202), providing both investors and the companies they invest in security without worry of losing access to the critical incentive in the future.

Continue reading→

iMetabolic Biopharma Corporation Announces Expansion of its Strategic OmniAb Antibody Discovery Partnership with Ligand Pharmaceuticals Accelerating iMetabolic’s iPlatform™ Technology and Pipeline Development

Posted on by

TEMPE, Ariz.–(BUSINESS WIRE)–iMetabolic Biopharma Corporation (iMBP) announces expansion of its strategic partnership relationship with Ligand Pharmaceuticals, building on an earlier alliance agreement initiated in 2018, giving access to Ligand’s OmniAb platform. Continue reading→

Rockefeller Foundation’s third National Covid-19 Testing Action Plan calls on the U.S. government to massively scale up Covid-19 testing

Posted on by

Rockefeller Foundation’s third National Covid-19 Testing Action Plan calls on the U.S. government to massively scale up Covid-19 testing an lays out a new plan for the largest domestic testing scale up to date and proposes 14 executive actions for the current and incoming administrations to take in order to rapidly alter the trajectory of the pandemic in the United States. Testing all U.S. public K-12 public schools would cost $42.5 billion, or $8.5 billion per month for the remainder of the school year from February to June 2021.Continue reading→

Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19

Posted on by
  • U.S. FDA authorizes COVID-19 mRNA vaccine for emergency use; companies are prepared to deliver first doses in the U.S. immediately
  • Pfizer and BioNTech previously announced an agreement with the U.S. Government to supply doses in 2020 & 2021
    In collaboration with Operation Warp Speed, Pfizer and BioNTech, as well as other vaccine companies are expected to deliver hundreds of millions of vaccine doses to Americans by the end of 2021
  • Historic science-driven efforts will seek to help bring an end to the most devastating pandemic in a century
  • Pfizer and BioNTech expect to file a Biologics License Application for possible full regulatory approval in 2021

Continue reading→

AZBio Celebrates Trailblazers in 2020

Posted on by

Each year, AZBio looks back across the legislative session to identify those leaders whose actions and active engagement support the growth of Arizona’s life science and healthcare industry and help to ensure the people of Arizona benefit from its success.  Scores are then tallied and the top ten legislative leaders are named the year’s Trailblazers.Continue reading→